0H0

Carbohydrate component from a pentavalent N-acetylneuraminic acid conjugate

Created:	2021-06-05
Last modified:	2021-10-13

Find Related PDB Entry
1 entries where 0H0 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	52
Chiral Atom Count	6
Bond Count	52
Aromatic Bond Count	0

2D diagram of 0H0

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Carbohydrate component from a pentavalent N-acetylneuraminic acid conjugate
Synonyms	(1R,2R)-1-[(2R,3R,4S,6R)-6-[bis(oxidanyl)methyl]-3-(1-hydroxyethylamino)-4-oxidanyl-6-propoxy-oxan-2-yl]propane-1,2,3-triol; (2R,4S,5R,6R)-5-acetamido-2-butoxy-4-oxidanyl-6-[(1R,2R)-1,2,3-tris(oxidanyl)propyl]oxane-2-carboxylic acid
Systematic Name (OpenEye OEToolkits)	(2~{R},4~{S},5~{R},6~{R})-5-acetamido-2-butoxy-4-oxidanyl-6-[(1~{R},2~{R})-1,2,3-tris(oxidanyl)propyl]oxane-2-carboxylic acid
Formula	C₁₅ H₂₇ N O₉
Molecular Weight	365.376
Type	SACCHARIDE

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CCCCO[C]1(C[CH](O)[CH](NC(C)=O)[CH](O1)[CH](O)[CH](O)CO)C(O)=O
SMILES	OpenEye OEToolkits	2.0.7	CCCCOC1(CC(C(C(O1)C(C(CO)O)O)NC(=O)C)O)C(=O)O
Canonical SMILES	CACTVS	3.385	CCCCO[C@@]1(C[C@H](O)[C@@H](NC(C)=O)[C@@H](O1)[C@H](O)[C@H](O)CO)C(O)=O
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCCCO[C@@]1(C[C@@H]([C@H]([C@@H](O1)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O
InChI	InChI	1.03	InChI=1S/C15H27NO9/c1-3-4-5-24-15(14(22)23)6-9(19)11(16-8(2)18)13(25-15)12(21)10(20)7-17/h9-13,17,19-21H,3-7H2,1-2H3,(H,16,18)(H,22,23)/t9-,10+,11+,12+,13+,15+/m0/s1
InChIKey	InChI	1.03	HDYHZAZYSDVKLZ-FSTWUICMSA-N

Related Resource References

Resource Name	Reference
PubChem	156613435

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.